Skip to main content

olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide

NDC 63629-2238 · Bryant Ranch Prepack

Generic nameolmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE, HYDROCHLOROTHIAZIDE
Strength5; 12.5; 20 mg/1; mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

63629-2238-1 — 30 TABLET, FILM COATED in 1 BOTTLE (63629-2238-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

63187-918 — Losartan Potassium and Hydrochlorothiazide, 63187-943 — Valsartan and Hydrochlorothiazide, 63187-981 — Irbesartan and Hydrochlorothiazide, 63629-1023 — Amlodipine besylate, 63629-1024 — Amlodipine besylate, 63629-1068 — Spironolactone and Hydrochlorothiazide, 63629-1069 — Spironolactone and Hydrochlorothiazide, 63629-1071 — Spironolactone and Hydrochlorothiazide, 63629-1218 — Hydrochlorothiazide, 63629-1220 — Hydrochlorothiazide, 63629-2239 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 63629-2240 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 63629-2241 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 63629-2430 — losartan potassium and hydrochlorothiazide, 63629-2431 — losartan potassium and hydrochlorothiazide, 63629-2585 — Triamterene and Hydrochlorothiazide, 63629-3739 — Lisinopril and Hydrochlorothiazide, 63629-4307 — Olmesartan Medoxomil and Hydrochlorothiazide, 63629-4470 — Lisinopril and Hydrochlorothiazide, 63629-7282 — Valsartan and Hydrochlorothiazide, +1450 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels